Tech Company Financing Transactions
Mission Bio Funding Round
Mission Bio closed a funding round on 8/6/2025. Backers included Ally Bridge Group and private investors.
Transaction Overview
Company Name
Announced On
8/6/2025
Transaction Type
Venture Equity
Amount
Unknown
Round
Undisclosed
Investors
Ally Bridge Group (Lead Investor)
Proceeds Purpose
The company intends to use the funds to further enhance its commercial partnerships, and clinical adoption to accelerate clinical adoption of its Tapestri platform across multiple cancer segments by providing crucial insights into treatment decision-making.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
6000 Shoreline Ct. 104
San Francisco, CA 94080
USA
San Francisco, CA 94080
USA
Phone
Website
Email Address
Overview
Mission Bio provides tools for the study of cellular heterogeneity in human health and life science research. Our approach relies on proprietary microfluidic droplet technology to deliver rapid and cost-effective solutions for molecular analysis of single cells.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Charlie Silver
Chief Financial Officer
Marcel Roche
Chief Technical Officer
Nigel Beard
Vice President
Anup Parikh
VP - Bus. Development
Darrin Crisitello
VP - Bus. Development
Harsha Kavuri
VP - Engineering
Adam Sciambi
VP - Human Resources
Sharon Hebrok
VP - Marketing
Hannah Viernes
VP - Product Management
Anjali Pradhan
VP - R & D
David Ruff
VP - Sales
George Kopitas
Browse more venture capital transactions:
Prev: 8/6/2025: Rillet venture capital transaction
Next: 8/6/2025: EON Space Labs venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs